October 4, 2026 4:02 PM ET
PolyPid Nears FDA Decision for D-PLEX100 After Strong Phase III Data
MarketBeat
PolyPid (NASDAQ:PYPD) is approaching a November 28 PDUFA date for D-PLEX100, its lead product candidate for preventing surgical site infections in patients undergoing colorectal surgery, Chief Executive Officer Dikla Czaczkes Akselbrad said during the Lytham Partners Fall 2026 Investor Conference.
NASDAQ:PYPD